يعرض 1 - 10 نتائج من 65 نتيجة بحث عن '"Kalogeras, K. T."', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
  4. 4
    دورية أكاديمية

    المساهمون: First Department of Medical Oncology, Hygeia Hospital, Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Department of Pathology, Section of Biostatistics, Hellenic Cooperative Oncology Group, Division of Oncology, Department of Medicine, University Hospital of Patras, Obstetrical and Gynaecological Center "Iasso", Department of Oncology, “Hippokration” Hospital, Third Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, School of medicine Thessaloniki, Aristotle University of Thessaloniki-Aristotle University of Thessaloniki, “Metropolitan” Hospital, Second Department of Internal Medicine, Propaedeutic, Oncology Section, “Attikon” University Hospital, Department of Medical Oncology, Translational Research Section, Second Department of Medical Oncology

    المصدر: ISSN: 0167-6806.

    مصطلحات موضوعية: Breast cancer, HER2, Trastuzumab, Predictive, PTEN, PIK3CA

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

    المصدر: Cancer chemotherapy and pharmacology

    مصطلحات موضوعية: Oncology, Survival rate, Scoring system, Messenger rna, Cell, Toxicology, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, Pharmacology (medical), Rac gtpase activating protein 1 gene, Ki-67 antigen, Quantitative analysis, Disease free survival, Survival time, Gene expression regulation, GTPase-Activating Proteins, Prognosis, Gene Expression Regulation, Neoplastic, Survival Rate, Retrospective study, Paclitaxel, Reverse transcription polymerase chain reaction, Regression Analysis, Human, medicine.medical_specialty, Major clinical study, Nottingham prognostic index, Disease-Free Survival, Article, Cancer grading, Randomized controlled trials as topic, Disease association, Humans, RNA, Messenger, Cyclophosphamide, Retrospective Studies, Aged, Pharmacology, Cancer prognosis, Patient Selection, medicine.disease, Retrospective studies, Drug effect, Ki-67 Antigen, Methotrexate, Gene identification, chemistry, Protein expression, Risk factor, Gene expression, Breast neoplasms, Cancer Research, Unclassified drug, Messenger, Metastasis, Qrt-pcr, Cancer risk, chemistry.chemical_compound, Randomized controlled trial (topic), Patient selection, Guanosine triphosphatase activating protein, Overall survival, Gtpase-activating proteins, Middle aged, Reverse transcriptase polymerase chain reaction, Randomized Controlled Trials as Topic, Priority journal, Risk assessment, Reverse Transcriptase Polymerase Chain Reaction, Middle Aged, Primary tumor, medicine.anatomical_structure, Real-time polymerase chain reaction, Nottingham Prognostic Index, Female, Fluorouracil, Protein determination, Regression analysis, Prognostic value, Ki67, Epirubicin, medicine.drug, Adult, Proportional hazards models, Disease-free survival, Histopathology, Breast Neoplasms, Young Adult, Antineoplastic combined chemotherapy protocols, Internal medicine, medicine, Early cancer, Human tissue, Racgap1, Oncogene, Proportional Hazards Models, Neoplastic, business.industry, Cancer survival, High risk patient, Young adult, Multivariate analysis, Rac gtpase activating protein 1, Multivariate Analysis, Rna, Ki 67 antigen, Prediction, business, Controlled study, Gene function

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Kotoula, V. 0000-0002-8657-9732

    المصدر: BMC Cancer